Explosive Penny Stocks

[Stock Rockstar]

PXYN Reports $55 Mill in Nine Months

PXYN Reports $55 Million in Revenues for First Nine Months of 2014
Last Updated: Nov. 14, 2014 - 10:00am EST

(NEW YORK)--Praxsyn Corporation (OTC:PXYN), which provides doctors with an alternative to oral pain medications, announced in a late notification filing that the company should report $23 million in revenue for the most recent quarter, and net income profit of $400,000

For the nine months ending Sept. 30, 2014, the Company will be reporting total revenues of roughly $55 million, as compared to just $4 million for the same nine month period in 2013. In addition to this sharp increases in revenues, the Company also reported that for the quarter ending Sept. 30, 2014, they would be reporting a net income profit of $400,000 as well.

With roughly 340 million common shares issued and outstanding, based on current revenues, PXYN is still trading well below 1 times 9 month reported revenue sales.

What has been causing the dramatic increase in revenues for the Company is PXYN recent acquisition of Mesa Pharmacy, Inc., which provides custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics.

Over the weekend, a very good and detailed outline on PXYN was written on SeekingAlpha. This gives any new traders a real feel for the potential that PXYN may be about to announce. You can find this article by going to http://seekingalpha.com/symbol/PXYN/instablogs

About Ludlow Research

Ludlow Research is a New York based equity research firm focused on providing our clients, and individual readers, with in-depth research coverage and opinions on the small-cap securities market. For over 14 years we have aimed to providing our subscribers a simple way of evaluating the current and potential value of small-cap stocks, and any risks that may effect those valuations going forward. Our goal is to provide traders with an easy way to make investment decisions based on current and future valuations. Ludlow Equity Research is a division of Ludlow Capital, Inc. www.ludlowresearch.com

In addition to PXYN, Ludlow Research has also placed Millennium Healthcare (OTC:MHCC) and Tristar Wellness Solutions (OTC:TWSI) both on "earnings watch" as both companies have pre-announced higher earnings guidance for their coming quarterly results.
http://www.wallstreetnewscast.com/profile/pxyn.html